CLINICAL_TRIALS
withdrawal
· 2015-04-10
Clinical Trial Update: A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma [Phase 2]
Summary
A Phase 2 trial evaluating the safety and effectiveness of golimumab in patients with severe, persistent asthma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Asthma | Phase 2 | Status: WITHDRAWN